20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Buprenorphine hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2010-291 - Rev 00
This Chemical Type CEP, issued on April 11, 2016, remains in force until July 05, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 1181 associated with this CEP further emphasizes